- Home
- ANVS vs ITRG Comparison
ANVS vs ITRG Comparison
Compare ANVS & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | ITRG |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | United States | Canada |
| Employees | N/A | 329 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 557.9M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ANVS | ITRG |
|---|---|---|
| Price | $1.31 | $2.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $13.50 | $5.13 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $67.34 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $1.99 |
| 52 Week High | $5.50 | $4.87 |
Technical Indicators
Market Signals| Indicator | ANVS | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 50.73 |
| Support Level | $1.04 | $2.62 |
| Resistance Level | $2.43 | $2.80 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 76.79 | 48.92 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.